Replimune REPL
NASDAQ REPL
$15.04 -0.25 (-1.64%)
As of: Sep 4, 2026 · 3:59 PM EDT

Replimune (REPL) Operating Leases (2018 - 2026)

Replimune (REPL) posted Operating Leases of $2.3 million for Q1 2026, down 37.54% sequentially from $3.7 million in Q4 2025, and down 24.32% YoY from $3.1 million in Q1 2025.

Analysis

Replimune (REPL) Operating Leases (2018 - 2026) Analysis & Trends

Replimune has reported Operating Leases for 9 years, with the latest figure at $2.3 million in Q1 2026.

  • Quarterly Operating Leases fell 24.32% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 24.32% YoY) and the FY2026 annual result came in at $2.3 million, down 24.32% from the prior year.
  • Operating Leases declined to $2.3 million in Q1 2026 per REPL's latest filing, from $3.7 million in the prior quarter.
  • Over five years, Operating Leases peaked at $32.8 million in Q1 2022 and troughed at $2.3 million in Q1 2026.
  • A 5-year average of $10.6 million and a median of $4.4 million in 2023 frame the typical range for Operating Leases.
  • The widest YoY moves for Operating Leases: up 637.78% in 2023, down 86.63% in 2023.
  • Over 5 years, Operating Leases stood at $4.3 million in 2022, then surged by 635.69% to $31.4 million in 2023, then slumped by 86.01% to $4.4 million in 2024, then retreated by 15.08% to $3.7 million in 2025, then tumbled by 37.54% to $2.3 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $2.3 million, $3.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Replimune 1.46 Bn 1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.27 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 28.72 Mn
Sep 30, 2025 29.12 Mn
Jun 30, 2025 29.54 Mn
Mar 31, 2025 3.08 Mn
Dec 31, 2024 30.08 Mn
Sep 30, 2024 30.55 Mn
Jun 30, 2024 30.76 Mn
Mar 31, 2024 31.06 Mn
Dec 31, 2023 31.38 Mn
Sep 30, 2023 31.58 Mn
Jun 30, 2023 31.93 Mn
Mar 31, 2023 32.11 Mn
Dec 31, 2022 32.01 Mn
Sep 30, 2022 32.09 Mn
Jun 30, 2022 32.47 Mn
Mar 31, 2022 32.84 Mn
Dec 31, 2021 33.10 Mn
Sep 30, 2021 32.91 Mn